Literature DB >> 24905419

Organometallic nucleoside analogues with ferrocenyl linker groups: synthesis and cancer cell line studies.

Huy V Nguyen1, Antoine Sallustrau, Jan Balzarini, Matthew R Bedford, John C Eden, Niki Georgousi, Nikolas J Hodges, Jonathan Kedge, Youcef Mehellou, Chris Tselepis, James H R Tucker.   

Abstract

Examples of organometallic compounds as nucleoside analogues are rare within the field of medicinal bioorganometallic chemistry. We report on the synthesis and properties of two chiral ferrocene derivatives containing a nucleobase and a hydroxyalkyl group. These so-called ferronucleosides show promising anticancer activity, with cytostatic studies on five different cancer cell lines indicating that both functional groups are required for optimal activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24905419     DOI: 10.1021/jm500246h

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden.

Authors:  Christian Prinz; Elena Vasyutina; Gregor Lohmann; Alexandra Schrader; Steffen Romanski; Christoph Hirschhäuser; Petra Mayer; Corazon Frias; Carmen D Herling; Michael Hallek; Hans-Günther Schmalz; Aram Prokop; Dimitrios Mougiakakos; Marco Herling
Journal:  Mol Cancer       Date:  2015-06-04       Impact factor: 27.401

2.  A new generation of ferrociphenols leads to a great diversity of reactive metabolites, and exhibits remarkable antiproliferative properties.

Authors:  Yong Wang; Patrick M Dansette; Pascal Pigeon; Siden Top; Michael J McGlinchey; Daniel Mansuy; Gérard Jaouen
Journal:  Chem Sci       Date:  2017-11-16       Impact factor: 9.825

3.  Organometallic Nucleosides: Synthesis and Biological Evaluation of Substituted Dicobalt Hexacarbonyl 2'-Deoxy-5-oxopropynyluridines.

Authors:  Renata Kaczmarek; Dariusz Korczyński; Karolina Królewska-Golińska; Kraig A Wheeler; Ferman A Chavez; Agnieszka Mikus; Roman Dembinski
Journal:  ChemistryOpen       Date:  2018-01-18       Impact factor: 2.911

Review 4.  Recent Advances in the Chemical Synthesis and Evaluation of Anticancer Nucleoside Analogues.

Authors:  Mieke Guinan; Caecilie Benckendorff; Mark Smith; Gavin J Miller
Journal:  Molecules       Date:  2020-04-28       Impact factor: 4.411

5.  A ferrocene-containing nucleoside analogue targets DNA replication in pancreatic cancer cells.

Authors:  Marium Rana; Alessio Perotti; Lucy M Bisset; James D Smith; Emma Lamden; Zahra Khan; Media K Ismail; Katherine Ellis; Katie A Armstrong; Samantha L Hodder; Cosetta Bertoli; Leticia Meneguello; Robertus A M de Bruin; Joanna R Morris; Isolda Romero-Canelon; James H R Tucker; Nikolas J Hodges
Journal:  Metallomics       Date:  2022-07-25       Impact factor: 4.636

6.  Purine and Purine Isostere Derivatives of Ferrocene: An Evaluation of ADME, Antitumor and Electrochemical Properties.

Authors:  Valentina Rep; Martina Piškor; Helena Šimek; Petra Mišetić; Petra Grbčić; Jasna Padovan; Vesna Gabelica Marković; Dijana Jadreško; Krešimir Pavelić; Sandra Kraljević Pavelić; Silvana Raić-Malić
Journal:  Molecules       Date:  2020-03-29       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.